SCHEMBL133529

SCHEMBL133529

O=C(O)CCCCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.69
HDAC3 O15379 3/20 0.69
HDAC4 P56524 3/20 0.69
HDAC1 Q13547 3/20 0.69
HDAC7 Q8WUI4 3/20 0.69
HDAC2 Q92769 3/20 0.69
HDAC10 Q969S8 3/20 0.69
HDAC11 Q96DB2 3/20 0.69
HDAC6 Q9UBN7 3/20 0.69
HDAC9 Q9UKV0 3/20 0.69
HDAC5 Q9UQL6 3/20 0.69
HPGD P15428 5/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
KMT2A Q03164 3/20 0.65
MEN1 O00255 2/20 0.65
L3MBTL1 Q9Y468 2/20 0.63
TDP1 Q9NUW8 1/20 0.63
ALDH1A1 P00352 3/20 0.62
MAPK1 P28482 1/20 0.62
GAA P10253 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31035987 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9947534 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9130049 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9350109 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4202491 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL3468927 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL3468449 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9899475 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL607631 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL10670786 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102491400-B Amino-functional water-soluble gadolinium oxide nanometer sheet and preparation method and application thereof UNIV SHANGHAI 2013-12-25 CN claimed
WO-2012076345-A1 COSMETIC COMPOSITION COMPRISING AN IMIDOPEROXYCARBOXYLIC ACID, AN IMIDOCARBOXYLIC ACID AND COPOLYMER OF 2-ACRYLAMIDO-2-METHYLPROPANESULPHONIC ACID L'OREAL (FR) 2012-06-14 WO claimed
CN-102491400-A Amino-functional water-soluble gadolinium oxide nanometer sheet and preparation method and application thereof UNIV SHANGHAI 2012-06-13 CN claimed
CN-102442703-A Preparation method of amino functionalized water-soluble manganese ferrate magnetic nanometer particles UNIV SHANGHAI 2012-05-09 CN claimed
CN-102320664-A Preparation method for amino-functionalized water-soluble magnetic manganomanganic oxide nanoparticles UNIV SHANGHAI 2012-01-18 CN claimed
EP-0790974-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS Bayer Corporation (US) 1997-08-27 EP claimed
EP-0473637-B1 PEROXYACID MANUFACTURE SOLVAY INTEROX LTD (GB) 1995-03-22 EP claimed
WO-1994013776-A1 AQUEOUS BLEACHING COMPOSITIONS COMPRISING PEROXY CARBOXYLIC ACIDS UNILEVER PLC (GB) 1994-06-23 WO claimed
US-5220052-A Controlling the rate of addition of a solution of carboxylic acid in concentrated sulfuric acid to Caro's solution having a particular range of components, i.e. hydrogen peroxide, water and sulfuric acid INTEROX CHEMICALS LIMITED (GB) 1993-06-15 US claimed
US-5208340-A Acid catalysts and circulation of solvents AUSIMONT S.P.A. (IT) 1993-05-04 US claimed
EP-0473637-A1 PEROXYACID MANUFACTURE. INTEROX CHEMICALS LTD (GB) 1992-03-11 EP claimed
WO-1990014336-A1 PEROXYACID MANUFACTURE INTEROX CHEMICALS LIMITED (GB) 1990-11-29 WO claimed
EP-4288481-B1 PROCESS FOR MODIFYING AN AROMATIC POLYETHER BACKBONE AND A MODIFIED POLYETHER OBTAINED BY THIS PROCESS UNIV BERLIN TECH (DE) 2026-05-06 EP disclosed
US-20260083653-A1 COMPONENT SYSTEM AND METHOD FOR PREPARING A TOOTH WHITENING PREPARATION COBEA AG (CH) 2026-03-26 US disclosed
US-20260002093-A1 Concentrated Liquid Rinse Aid Suitable for Dilution And Repeated Use RECKITT BENCKISER FINISH BV (NL) 2026-01-01 US disclosed
EP-4590264-A1 COMPONENT SYSTEM AND METHOD FOR PREPARING A TOOTH WHITENING PREPARATION Cobea AG (CH) 2025-07-30 EP disclosed
US-RE32868-E Antihyperlipidemic compositions RESEARCH CORPORATION (US) 1989-02-14 US disclosed
EP-0214112-A2 Polyester compositions containing phthalimidoesters Monsanto Company (US) 1987-03-11 EP disclosed
EP-0188361-A1 Amine derivatives GLAXO GROUP LIMITED (GB) 1986-07-23 EP disclosed
US-4395417-A Antihyperlipidemic compositions RESEARCH CORPORATION (US) 1983-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002093-A1 Concentrated Liquid Rinse Aid Suitable for Dilution And Repeated Use ABHD12, ADH1A, ADH1C HDAC8 3609/4885HDAC3 4661/4885HDAC4 4678/4885
US-20260083653-A1 COMPONENT SYSTEM AND METHOD FOR PREPARING A TOOTH WHITENING PREPARATION PRKX, PRKACA, CAPN1 HDAC8 2205/4885HDAC3 1882/4885HDAC4 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.